Oral Communication on Acquired Bleeding

Thursday 23 October

Abstract titles & Authors

Moderators: John Bjarne Hansen, Claire de Moreuil

09.00
09.15

OC07-OP01 – INCIDENCE AND ANATOMICAL DISTRIBUTION OF RECURRENT MAJOR BLEEDING IN INCIDENT ATRIAL FIBRILLATION PATIENTS ON ORAL ANTICOAGULANTS: A POPULATION-BASED COHORT STUDY IN THE NETHERLANDS (2015-2022) – Zihua Li, Leiden University Medical Center

09.15
09.30

OC07-OP02 – QUANTITATIVE TARGETED PROTEOMICS IDENTIFIES NOVEL BIOMARKERS FOR PREDICTION OF MAJOR BLEEDING DURING ANTICOAGULATION: A PROSPECTIVE CASE-COHORT STUDY – Eleonora Camilleri, LUMC

09.30
09.45

OC07-OP03 – DIRECT ORAL ANTICOAGULANTS IN THE POSTPARTUM PERIOD: REPORT OF REAL-LIFE EXPERIENCE IN THE HEMOTHEPP COHORT STUDY – Claire de Moreuil, Brest University Hospital

09.45
10.00

OC07-OP04 – MONITORING OF ANTI-XA ACTIVITY OF ENOXAPARIN IN HEMODIALYSIS PATIENTS – Habib Bendani, Hôpital universitaire d’Oran. Algérie

10.00
10.15

OC07-OP05 – WORSE CLINICAL OUTCOME IN YOUNG WOMEN TREATED WITH VITAMIN K ANTAGONISTS FOR MECHANICAL HEART VALVES COMPARED TO MEN: A DUTCH POPULATION-BASED COHORT STUDY – Marieke Kruip, Erasmus MC

10.15
10.30

OC07-OP06 – EVALUATION OF DOAC-LEVELS IN ACUTELY ADMITTED FRAIL OLDER PATIENTS: AN EXPLORATORY STUDY (THE DOAC-FRAIL STUDY) – Melanie Jong, MUMC+